Vibha Oza

Rational design of potent human transthyretin amyloid disease inhibitors.

James C. Sacchettini, Thomas Klabunde, H. Michael Petrassi et al. · Nature Structural Biology · 2000 · 370 citations

Medicine, Rational Design, Rational Drug Design +3

Synthesis and evaluation of inhibitors of transthyretin amyloid formation based on the non-steroidal anti-inflammatory drug, flufenamic acid

Paul W. Baures, Vibha Oza, Scott Peterson et al. · Bioorganic & Medicinal Chemistry · 1999 · 135 citations

Medicinal Chemistry, Pharmaceutical Science, Biochemistry +9

Synthesis, Structure, and Activity of Diclofenac Analogues as Transthyretin Amyloid Fibril Formation Inhibitors

Vibha Oza, Craig Smith, Prakash Raman et al. · Journal of Medicinal Chemistry · 2001 · 131 citations · Full text

Combinatorial Chemistry, Medicinal Chemistry, Pharmaceutical Science +13

Discovery of a Novel Class of Dimeric Smac Mimetics as Potent IAP Antagonists Resulting in a Clinical Candidate for the Treatment of Cancer (AZD5582)

Edward J. Hennessy, Ammar Adam, Brian Aquila et al. · Journal of Medicinal Chemistry · 2013 · 112 citations · Full text

Compound 14, Apoptosis, Cell Death +18

Synthesis and evaluation of anthranilic acid-based transthyretin amyloid fibril inhibitors

Vibha Oza, H. Michael Petrassi, Hans E. Purkey et al. · Bioorganic & Medicinal Chemistry Letters · 1999 · 78 citations

Molecular Pharmacology, Medicinal Chemistry, Biochemistry +9